Efficacy of Repositioning Therapy in Patients With Benign Paroxysmal Positional Vertigo and Preexisting Central Neurologic Disorders
With the exception of migraines, benign paroxysmal positional vertigo (BPPV) in patients with preexisting central neurologic disorders (CND) is rarely discussed in the literature. Demographic features of this patient group and the efficacy of repositioning therapy are still unknown. We hypothesized...
Main Authors: | Chih-Chung Chen, Hsiao-Shan Cho, Hsun-Hua Lee, Chaur-Jong Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2018.00486/full |
Similar Items
-
An Evaluation of the Effects of Betahistine and Dimenhydrinate on Posterior Canal Benign Paroxysmal Positional Vertigo
by: Hakkı Caner İnan, et al.
Published: (2019-12-01) -
Residual dizziness after successful repositioning maneuver for idiopathic benign paroxysmal positional vertigo: a review
by: Giorgia Giommetti, et al.
Published: (2017-05-01) -
Treatment Efficacy of Various Maneuvers for Lateral Canal Benign Paroxysmal Positional Vertigo With Apogeotropic Nystagmus: A Randomized Controlled Trial
by: Hyun Jin Lee, et al.
Published: (2023-08-01) -
Betahistine add-on therapy for treatment of subjects with posterior benign paroxysmal positional vertigo: a randomized controlled trial
by: Ibrahim Sayin, et al.
Published: (2022-05-01) -
A comparative study of two methods for treatment of benign paroxysmal positional vertigo in the emergency department
by: D. Giardino, et al.
Published: (2021-10-01)